SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. (Q31841874)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. |
scientific article |
Statements
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia (English)
F C Barone
E A Irving
A M Ray
J C Lee
S Kassis
S Kumar
A M Badger
R F White
M J McVey
J J Legos
J A Erhardt
A H Nelson
E H Ohlstein
A J Hunter
K Ward
B R Smith
J L Adams